Royal Bank of Canada cut its target price for aTyr Pharma, which was reported by Benzinga.
1 report, 1 independent
Updated Fri 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada cut its target price for aTyr Pharma, which was reported by Benzinga.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
aTyr Pharma
company in San Diego, United States
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada issued a price objective and Benzinga reported a target price reduction for Aardvark Therapeutics, Inc.
- Royal Bank of Canada raised its price objective for Vertex Pharmaceuticals, with Benzinga and MarketBeat reporting related analyst changes.
- Financial institutions Morgan Stanley, Royal Bank of Canada, and Citigroup issued various rating and price target updates for Howmet Aerospace.